Lineage enters race to Huntington’s market with NeuroAirmid takeover
Lineage hopes that hNSC-01, a novel cell therapy, could offer symptomatic and disease-slowing benefits in Huntington’s.
Lineage hopes that hNSC-01, a novel cell therapy, could offer symptomatic and disease-slowing benefits in Huntington’s.